https://www.marketscreener.com/quote/stock/THERAVANCE-BIOPHARMA-INC-16501278/news/Theravance-Biopharma-Announces-Results-from-the-Phase-4-YUPELRI-PIFR-2-Study-in-Patients-with-Sev-45680666/?utm_source=telegram&utm_medium=social&utm_campaign=share